Ország: Egyesült Államok
Nyelv: angol
Forrás: NLM (National Library of Medicine)
FLUDARABINE PHOSPHATE (UNII: 1X9VK9O1SC) (FLUDARABINE - UNII:P2K93U8740)
Mylan Institutional LLC
FLUDARABINE PHOSPHATE
FLUDARABINE PHOSPHATE 25 mg in 1 mL
PRESCRIPTION DRUG
Abbreviated New Drug Application
FLUDARABINE PHOSPHATE- FLUDARABINE PHOSPHATE INJECTION MYLAN INSTITUTIONAL LLC ---------- FLUDARABINE PHOSPHATE INJECTION, USP RX ONLY FOR INTRAVENOUS USE ONLY WARNING Fludarabine Phosphate Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Fludarabine Phosphate Injection can severely suppress bone marrow function. When used at high doses in dose-ranging studies in patients with acute leukemia, fludarabine phosphate injection was associated with severe neurologic effects, including blindness, coma, and death. This severe central nervous system toxicity occurred in 36% of patients treated with doses approximately four times greater (96 mg/m /day for 5–7 days) than the recommended dose. Similar severe central nervous system toxicity, including coma, seizures, agitation and confusion, has been reported in patients treated at doses in the range of the dose recommended for chronic lymphocytic leukemia. Instances of life-threatening and sometimes fatal autoimmune phenomena such as hemolytic anemia, autoimmune thrombocytopenia/thrombocytopenic purpura (ITP), Evans syndrome, and acquired hemophilia have been reported to occur after one or more cycles of treatment with fludarabine phosphate injection. Patients undergoing treatment with fludarabine phosphate injection should be evaluated and closely monitored for hemolysis. In a clinical investigation using fludarabine phosphate injection in combination with pentostatin (deoxycoformycin) for the treatment of refractory chronic lymphocytic leukemia (CLL), there was an unacceptably high incidence of fatal pulmonary toxicity. Therefore, the use of fludarabine phosphate injection in combination with pentostatin is not recommended. DESCRIPTION Fludarabine Phosphate Injection contains fludarabine phosphate, a fluorinated nucleotide analog of the antiviral agent vidarabine, 9-ß D-arabinofuranosyladenine (ara-A) that is relatively resistant to deamination by adenosine deaminase. Each mL contains 25 m Olvassa el a teljes dokumentumot